# Starling Oncology, Inc.: Form 8-K, filed Jun 18, 2026

- Company: [Starling Oncology, Inc.](/companies/stln.md) (CIK 1799191)
- Form: 8-K
- Filed: 2026-06-18
- Accepted by EDGAR: Jun 18, 2026, 16:30 ET
- Period: 2026-06-17
- Accession: 0001553350-26-000093
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/toi_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/toi_8k.htm

Filed Jun 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001553350-26-000093. Last ingested by Listed: Nov 15, 2026, 04:34 ET. No prices; not investment advice.
